The importance of pharma CSRThe industry is increasingly aware of the importance of corporate social responsibility (CSR) programmes – and Alex Kalomparis, Share XThe importance of pharma CSRhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-importance-of-pharma-csr/
Can in vivo imaging deliver the full potential of immunotherapy?In the quest to control cancer we now face the challenge of translating our increasing insights into the Share XCan in vivo imaging deliver the full potential of immunotherapy?https://pharmaphorum.com/views-analysis-oncology/can-in-vivo-imaging-deliver-the-full-potential-of-immunotherapy/
10 tips for successful modern signatoriesThe term “gate-keeper” implies only signatories are concerned with compliance with the ABPI Code of Practice, so we Share X10 tips for successful modern signatorieshttps://pharmaphorum.com/views-analysis-sales-marketing/10-tips-for-successful-modern-signatories/
Making patient involvement meaningfulTrue public and patient involvement in research needs to be more than just a box ticking exercise – Share XMaking patient involvement meaningfulhttps://pharmaphorum.com/views-analysis-patients/making-patient-involvement-meaningful/
Achieving launch excellence in orphan medicinesNew rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking Share XAchieving launch excellence in orphan medicineshttps://pharmaphorum.com/market-access-2/achieving-launch-excellence-in-orphan-medicines/
Why pharma needs to care about global warmingBarely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by Share XWhy pharma needs to care about global warminghttps://pharmaphorum.com/views-and-analysis/why-pharma-needs-to-care-about-global-warming/
As cancer treatments evolve, so must investment mechanismsLast month’s American Society of Clinical Oncology (ASCO) meeting kicked off with a presentation from Professor Ruth Plummer, Share XAs cancer treatments evolve, so must investment mechanismshttps://pharmaphorum.com/views-analysis-oncology/as-cancer-treatments-evolve-so-must-investment-mechanisms/
The changing face of pharma’s customer engagementSarah Rickwood looks at five key trends in the new customer model It is easy to be distracted Share XThe changing face of pharma’s customer engagementhttps://pharmaphorum.com/views-analysis-sales-marketing/the-changing-face-of-pharmas-customer-engagement/
Will AI make pharma marketers obsolete?Artificial intelligence is sometimes seen as either a panacea or a destroyer – the fix for all humanity’s Share XWill AI make pharma marketers obsolete?https://pharmaphorum.com/views-analysis-digital/will-ai-make-pharma-marketers-obsolete/
